ID: ALA5085189

Max Phase: Preclinical

Molecular Formula: C51H62ClN9O9S

Molecular Weight: 1012.63

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COc1ccc2c(c1)-n1c(C)nnc1[C@H]([C@@H](C)C(=O)NCCOCCOCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCc1ccc(-c3scnc3C)cc1)C(C)(C)C)N=C2c1ccc(Cl)cc1

Standard InChI:  InChI=1S/C51H62ClN9O9S/c1-30(43-47-59-58-32(3)61(47)40-25-38(67-7)16-17-39(40)44(57-43)34-12-14-36(52)15-13-34)48(64)53-18-19-68-20-21-69-22-23-70-28-42(63)56-46(51(4,5)6)50(66)60-27-37(62)24-41(60)49(65)54-26-33-8-10-35(11-9-33)45-31(2)55-29-71-45/h8-17,25,29-30,37,41,43,46,62H,18-24,26-28H2,1-7H3,(H,53,64)(H,54,65)(H,56,63)/t30-,37-,41+,43+,46-/m1/s1

Standard InChI Key:  UBHASAXGTMHUOM-IFYMSMGQSA-N

Associated Targets(Human)

von Hippel-Lindau disease tumor suppressor/Bromodomain-containing protein 2 53 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 1012.63Molecular Weight (Monoisotopic): 1011.4080AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Bond AG, Craigon C, Chan KH, Testa A, Karapetsas A, Fasimoye R, Macartney T, Blow JJ, Alessi DR, Ciulli A..  (2021)  Development of BromoTag: A "Bump-and-Hole"-PROTAC System to Induce Potent, Rapid, and Selective Degradation of Tagged Target Proteins.,  64  (20.0): [PMID:34652918] [10.1021/acs.jmedchem.1c01532]

Source